Hostname: page-component-848d4c4894-75dct Total loading time: 0 Render date: 2024-05-06T19:50:16.023Z Has data issue: false hasContentIssue false

Radiotherapy for histiocytic sarcoma: a case report

Published online by Cambridge University Press:  09 January 2015

Daniel J. Bourgeois III
Affiliation:
Roswell Park Cancer Institute, Buffalo, NY, USA
Allison Dixon
Affiliation:
Roswell Park Cancer Institute, Buffalo, NY, USA
Anurag K. Singh*
Affiliation:
Roswell Park Cancer Institute, Buffalo, NY, USA
*
Correspondence to: Anurag K. Singh, MD, Roswell Park Cancer Institute, Elm & Carlton Streets, Buffalo, 14263 NY, USA. Tel: (716) 845 - 1180; E-mail: anurag.singh@roswellpark.org

Abstract

Background

Histiocystic sarcoma is a rare, but aggressive tumour that often involves extranodal sites. Histiocystic sarcoma is recognised by the World Health Organization as one of six subtypes of dendritic cell neoplasms. Diagnosis is difficult due to overlapping immunohistochemistry with other dendritic cell neoplasms. The optimal roles for chemotherapy, radiotherapy and surgery in the treatment of histiocytic sarcoma remain unknown.

Methods

We report a case of a patient with histiocytic sarcoma diagnosed after excisional biopsy and immunohistochemistry testing.

Results

The patient underwent external beam radiation therapy (EBRT). After 18 Gray (Gy), the 8 cm lesion had regressed to ~5 cm in diameter. The treatments were continued to a total dose of 45 Gy with the lesion regressing to less than a centimeter by the end of treatment. Local control was maintained but the patient died of acute myelogenous leukemia 5 months after her treatment.

Conclusions

This case suggests that histicytic sarcomas can be controlled locally with EBRT.

Type
Case Study
Copyright
© Cambridge University Press 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Jaffe, E S. Histiocytic and dendritic cell neoplasms. In: Jaffe E S, Harris N L, Stein, H et al. (eds), World Health Orgnization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001: 275277.Google Scholar
2.Wilson, M S, Weiss, L M, Gatter, K C, Mason, D Y, Darfman, R F, Warnke, R A. Malignant histiocytosis. a reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies. Cancer 1990; 66 (3): 530536.Google Scholar
3.Egeler, R Met al. Malignant histiocytosis: a reassessment of cases formerly classified as histiocytic neoplasms and review of the literature. Med Pediatr Oncol 1995; 25 (1): 17.Google Scholar
4.Gonzalez, C L, Jaffe, E S. The histiocytoses: clinical presentation and differential diagnosis. Oncology (Williston Park) 1990; 4 (11): 4760; discussion 60, 62.Google Scholar
5.Vos, J A , Abbondanzo, S L, Barekman, C L, Andriko, J W, Miettinen, M, Aguilera, N S. Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163. Mod Pathol 2005; 18 (5): 693704.Google Scholar
6.Almefty, R O, Tyree, T L, Fusco, D J, Coons, S W, Nakaji, P. Primary histiocytic sarcoma of the brain mimicking cerebral abscess. J Neurosurg Pediatr 2013; 12 (3): 251257.CrossRefGoogle ScholarPubMed
7.Buonocore, S, Valente, A L, Nightingale, D, Bogart, J, Souid, A K. Histiocytic sarcoma in a 3-year-old male: a case report. Pediatrics 2005; 116 (2): e322e325.Google Scholar
8.Hornick, J L, Jaffe, E S, Fletcher, C D. Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol 2004; 28 (9): 11331144.CrossRefGoogle ScholarPubMed
9.Mainardi, C, D’Amore, E S, Pillon, M, Toffolutti, T, Rosolen, A. A case of resistant pediatric histiocytic sarcoma successfully treated with chemo-radiotherapy and autologous peripheral blood stem cell transplant. Leuk Lymphoma 2011; 52 (7): 13671371.Google Scholar
10.Yoshida, C, Takeuchi, M. Histiocytic sarcoma: identification of its histiocytic origin using immunohistochemistry. Intern Med 2008; 47 (3): 165169.CrossRefGoogle ScholarPubMed